Reusable Minimally Invasive Surgical Instruments Market Global Report 2026

The reusable minimally invasive surgical instruments market size has grown strongly in recent years. It will grow from $2.39 billion in 2025 to $2.6 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing volume of minimally invasive surgical procedures, growing demand for cost effective surgical solutions, advancements in surgical instrument material technologies, expansion of healthcare infrastructure and surgical facilities, rising adoption of laparoscopic and endoscopic techniques.

The reusable minimally invasive surgical instruments market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to growing demand for reusable healthcare equipment, increasing number of outpatient surgical procedures, expansion of specialized surgical centers worldwide, rising investments in advanced surgical technologies, growing focus on reducing medical waste and operational costs. Major trends in the forecast period include growing adoption of reusable surgical instruments to reduce procedural costs, increasing preference for high durability stainless steel surgical instruments, rising demand for advanced sterilization compatible instrument designs, expansion of minimally invasive surgical procedures across healthcare facilities, development of ergonomic surgical instruments for improved surgeon precision.

The growing adoption of minimally invasive surgical procedures is expected to drive the growth of the reusable minimally invasive surgical instruments market going forward. Minimally invasive surgical procedures are advanced surgical techniques that involve smaller incisions, imaging assistance, and specialized instruments to perform procedures with reduced tissue trauma, lower complication risks, and faster recovery times. The adoption of these procedures is increasing due to advancements in medical technology, enhanced anesthesia methods, and healthcare systems focusing on shorter hospital stays, lower healthcare expenses, and improved surgical efficiency. Reusable minimally invasive surgical instruments support these procedures by offering cost-effective, precision-oriented, and sterilizable tools, including forceps, scissors, graspers, and retractors, that can be reused across multiple surgeries while maintaining accuracy and operational effectiveness. For instance, in February 2024, according to the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, approximately 83% of medical procedures performed in 2023 were minimally invasive, while conventional surgical procedures accounted for the remaining 17%. Additionally, in 2023, according to the American Society of Plastic Surgeons, a US-based specialty organization, the number of cosmetic minimally invasive procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the increasing adoption of minimally invasive surgical procedures is supporting the growth of the reusable minimally invasive surgical instruments market.

Major companies operating in the reusable minimally invasive surgical instruments market are focusing on product advancements, including flexible reusable ureteroscope systems, to improve visualization, enable better access to complex urinary tract anatomy, and enhance procedural precision in urological surgeries. Flexible reusable ureteroscopes are advanced endoscopic devices designed for minimally invasive diagnosis and treatment of conditions affecting the kidney and urinary tract, providing superior maneuverability, improved imaging capabilities, and the ability to undergo sterilization for repeated procedures. For instance, in February 2026, Stryker, a US-based medical technology company specializing in surgical equipment and endoscopic systems, launched the F88 Flexible Ureteroscope, a minimally invasive surgical instrument. The newly introduced reusable flexible ureteroscope is designed to strengthen Stryker’s urology portfolio by facilitating improved anatomical access through enhanced deflection capabilities and advanced imaging performance, supporting minimally invasive treatment of kidney stones and other urological disorders.

In August 2024, KARL STORZ, a Germany-based medical technology company, acquired Asensus Surgical for $95 million. Through this acquisition, KARL STORZ aimed to strengthen its robotic-assisted and minimally invasive surgery portfolio by integrating Asensus Surgical’s Performance-Guided Surgery technologies, digital laparoscopy capabilities, and next-generation LUNA robotic platform to expand its presence in the growing surgical robotics market. Asensus Surgical is a US-based medical device company that develops robotic-assisted and reusable minimally invasive surgical technologies for laparoscopic procedures.

Major companies operating in the reusable minimally invasive surgical instruments market report are Stryker Corporation, Medtronic plc, Johnson & Johnson, B. Braun SE, Olympus Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, CONMED Corporation, Zimmer Biomet, Smith & Nephew, Teleflex Incorporated, Becton Dickinson and Company, Arthrex, Applied Medical, Erbe Elektromedizin, KLS Martin Group, Intuitive Surgical, Getinge, Medicon eG, CooperSurgical, Encision Inc., Aspen Surgical Products.

North America was the dominating region in the reusable minimally invasive surgical instruments market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the reusable minimally invasive surgical instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the reusable minimally invasive surgical instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.